APYX News and Press, Apyx Medical Corporation From 10/02/23

Apyx ® Medical Corporation (NASDAQ:APYX) (the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion ® , today announced that financial results for the third quarter of fiscal year 2023 will be rele...

2023-08-24 10:30:54 ET Summary INMD's P/E and EV/EBITDA ratios have fallen sharply in the past 2-3 years despite its revenues and net income more than doubling in this period. The prospect of continued profitable growth and a history of beating analysts' estimates suggest that thi...

2023-08-12 12:09:10 ET Apyx Medical Corporation (APYX) Q2 2023 Earnings Conference Call August 01, 2023 05:00 PM ET Company Participants Charles Goodwin - President & CEO Tara Semb - CFO Conference Call Participants Matt Hewitt - Craig-Hallum Capital ...

2023-08-10 16:41:37 ET Apyx Medical press release ( NASDAQ: APYX ): Q2 GAAP EPS of -$0.03 beats by $0.04 . Revenue of $13.6M (+32.0% Y/Y) misses by $0.75M . For further details see: Apyx Medical GAAP EPS of -$0.03 beats by $0.04, revenue of $13.6M misses ...

Advanced Energy Sales increased 40% year-over-year in Q2 Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion ® , today reported financial results ...

2023-06-30 12:31:22 ET Gainers: Cyteir Therapeutics ( CYT ) +39% . Renalytix ( RNLX ) +39% . Rackspace Technology ( RXT ) +29% . Friedman Industries ( FRD ) +23% . Gracell Biotechnologies ( GRCL ) +23% . CytomX Therapeutics (...

2023-06-30 10:06:37 ET Gainers: CymaBay Therapeutics ( CBAY ) +36% . Cyteir Therapeutics ( CYT ) +34% . Renalytix ( RNLX ) +32% . CytomX Therapeutics ( CTMX ) +14% . Alvotech ( ALVO ) +13% . Losers: Unicycive Therapeutics ...

Apyx ® Medical Corporation (NASDAQ:APYX) (the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion ® , today announced that financial results for the second quarter of fiscal year 2023 will be rel...

Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion ® , today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (“FDA...

2023-05-18 10:04:28 ET Gainers: Enveric Biosciences ( ENVB ) +68% . Alimera Sciences ( ALIM ) +35% . Corvus Pharmaceuticals ( CRVS ) +12% . Viracta Therapeutics ( VIRX ) +11% . Bullfrog AI Holdings ( BFRG ) +8% . Losers: N...